Valuation: Steris PLC

Market Cap 2.03TCr 1.81TCr 1.69TCr 1.54TCr 2.9TCr 1,95500Cr 2.93TCr 20TCr 7.91TCr 1LCr 7.63TCr 7.47TCr 3,20700Cr P/E 2027 *
22.5x
P/E 2028 * 19.9x
Enterprise Value 2.17TCr 1.93TCr 1.8TCr 1.64TCr 3.09TCr 2,08500Cr 3.12TCr 22TCr 8.43TCr 1,06600Cr 8.14TCr 7.97TCr 3,42100Cr EV / Sales 2027 *
3.4x
EV / Sales 2028 * 3.15x
Free-Float
99.69%
Yield 2027 *
1.28%
Yield 2028 * 1.38%
Manager TitleAgeSince
Chief Executive Officer 53 29/07/2021
Director of Finance/CFO 59 18/08/2025
Compliance Officer - 01/08/2019
Director TitleAgeSince
Director/Board Member 73 01/03/2005
Director/Board Member 54 01/05/2018
Chairman 67 28/07/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 2.03TCr
+0.84%-3.74%-27.56%+1.93% 17TCr
-0.07%-2.55%-11.59%+13.26% 11TCr
+0.90%+1.13%-25.66%+3.47% 11TCr
+1.33%-0.96%-47.59%-11.23% 7.39TCr
-0.24%+0.69%+2.08%+69.19% 5.9TCr
+1.32%+3.86%+8.58%+61.88% 5.13TCr
-0.71%-3.82%-8.68%-31.93% 4.82TCr
+0.12%-0.17%-17.87%+19.66% 4.08TCr
-1.01%-1.45%+27.31%-2.67% 3.22TCr
Average +0.34%-0.86%-11.22%+13.73% 7.67TCr
Weighted average by Cap. +0.48%-1.30%-17.19%+11.25%

Financials

2027 *2028 *
Net sales 637.22Cr 566.17Cr 528.43Cr 481.65Cr 908.38Cr 61TCr 916.84Cr 6.39TCr 2.48TCr 31TCr 2.39TCr 2.34TCr 1,00500Cr 677.76Cr 602.19Cr 562.04Cr 512.28Cr 966.16Cr 65TCr 975.16Cr 6.8TCr 2.64TCr 33TCr 2.54TCr 2.49TCr 1,06900Cr
Net income 89Cr 79Cr 74Cr 67Cr 126.7Cr 8.54TCr 127.88Cr 891.94Cr 345.63Cr 4.37TCr 333.69Cr 326.45Cr 14TCr 101.91Cr 91Cr 85Cr 77Cr 145.28Cr 9.8TCr 146.63Cr 1.02TCr 396.32Cr 5.01TCr 382.63Cr 374.33Cr 16TCr
Net Debt 135.61Cr 120.49Cr 112.46Cr 102.5Cr 193.32Cr 13TCr 195.12Cr 1.36TCr 527.38Cr 6.66TCr 509.16Cr 498.11Cr 21TCr 102.11Cr 91Cr 85Cr 77Cr 145.56Cr 9.82TCr 146.91Cr 1.02TCr 397.07Cr 5.02TCr 383.36Cr 375.04Cr 16TCr
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-